R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair

Overview of attention for article published in Molecular Cancer, August 2010

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 37 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKERS INDICATIVE OF PROSTATE CANCER AND TREATMENT THEREOF

Application EP-3606536-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.